Small Molecule Immunomodulators as Next-Generation Therapeutics for Glioblastoma

Small Molecule Immunomodulators as Next-Generation Therapeutics for Glioblastoma

Glioblastoma (GBM), the most aggressive astrocytic glioma, remains a therapeutic challenge despite multimodal approaches. Immunotherapy holds promise, but its efficacy is hindered by the highly immunosuppressive GBM microenvironment. This review underscores the urgent need to comprehend the intricat...

Full description

Bibliographic Details
Main Authors:	Somaya A. Abdel-Rahman, Moustafa Gabr
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Cancers
Subjects:	small molecules immune checkpoints glioblastoma drug discovery immunomodulation immunosuppression
Online Access:	https://www.mdpi.com/2072-6694/16/2/435

Similar Items

Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches
by: Natalie Fuchs, et al.
Published: (2024-01-01)

Small molecule-based immunomodulators for cancer therapy
by: Yinrong Wu, et al.
Published: (2022-12-01)

The immunological activities and transcriptome analysis of a potent small-molecule immunomodulator
by: Yasser Tabana, et al.
Published: (2024-02-01)

New Frontiers in Immunological Therapeutics in the Critically Ill Patient: From Immunosuppression to Immunomodulation
by: Jorge Luis Vélez Paez
Published: (2023-10-01)

Novel Brain-Penetrant, Small-Molecule Tubulin Destabilizers for the Treatment of Glioblastoma
by: Lilian A. Patrón, et al.
Published: (2024-02-01)

Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds
by: Hui Liu, et al.
Published: (2022-04-01)

Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors in Treatment of Glioblastoma
by: LI Yingying, et al.
Published: (2022-05-01)

Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment
by: Davide Frumento, et al.
Published: (2024-01-01)

Plant Derived Immunomodulators; A Critical Review
by: Akey Krishna Swaroop, et al.
Published: (2022-08-01)

Dual-responsive supramolecular photodynamic nanomedicine with activatable immunomodulation for enhanced antitumor therapy
by: Siqin He, et al.
Published: (2024-02-01)

Secretion of immunomodulating neuropeptides (VIP, SP) and nitric oxide synthase in porcine small intestine during postnatal development
by: A. Kovsca Janjatovic, et al.
Published: (2012-09-01)

Amphipathic Small Molecule AZT Compound Displays Potent Inhibitory Effects in Cancer Cell Proliferation
by: Pethaiah Gunasekaran, et al.
Published: (2021-12-01)

Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8
by: Shravan Morla, et al.
Published: (2020-08-01)

Immunomodulation - hope for patient with Glioblastoma Multiforme
by: Jakub Litak, et al.
Published: (2018-09-01)

Immunomodulation - hope for patient with Glioblastoma Multiforme
by: Jakub Litak, et al.
Published: (2018-09-01)

Role of chemotherapeutic drugs in immunomodulation of cancer
by: Oishi Mukherjee, et al.
Published: (2023-01-01)

Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges
by: Monica A. Kamal, et al.
Published: (2022-08-01)

Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
by: Tsubasa Miyazaki, et al.
Published: (2020-07-01)

Introduction to small molecule drug discovery and preclinical development
by: Michelle W. Y. Southey, et al.
Published: (2023-11-01)

Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
by: Guillermo A. Videla-Richardson, et al.
Published: (2021-12-01)

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
by: Boyuan Huang, et al.
Published: (2023-02-01)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
by: Peixin Du, et al.
Published: (2022-12-01)

Expert opinion on translational research for advanced glioblastoma treatment
by: Xiaoteng Cui, et al.
Published: (2023-05-01)

Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through Immunomodulation
by: Kumar Jayant, et al.
Published: (2020-05-01)

A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment
by: Da Wang, et al.
Published: (2019-01-01)

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
by: Benjamin T. Himes, et al.
Published: (2021-10-01)

Thinking Small: Small Molecules as Potential Synergistic Adjuncts to Checkpoint Inhibition in Melanoma
by: Alexander C. Chacon, et al.
Published: (2021-03-01)

RNA-targeted small-molecule drug discoveries: a machine-learning perspective
by: Huan Xiao, et al.
Published: (2023-12-01)

Editorial: Soluble immune checkpoints: Novel physiological immunomodulators
by: Antonio Riva, et al.
Published: (2023-03-01)

The properties and mechanism of action of plant immunomodulators in regulation of immune response – A narrative review focusing on Curcuma longa L., Panax ginseng C. A. Meyer and Moringa oleifera Lam
by: Muggunna Balasubramaniam, et al.
Published: (2024-04-01)

Combating small-molecule aggregation with machine learning
by: Kuan Lee, et al.
Published: (2021-09-01)

Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma
by: Paula Aldaz, et al.
Published: (2021-01-01)

Improving targeted small molecule drugs to overcome chemotherapy resistance
by: Amirhossein Rismanbaf
Published: (2024-01-01)

Proof-of-Concept Preclinical Use of <i>Drosophila melanogaster</i> in the Initial Screening of Immunomodulators
by: Firzan Nainu, et al.
Published: (2022-02-01)

Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
by: Mark Dapash, et al.
Published: (2021-09-01)

Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells
by: Eileen Stoll, et al.
Published: (2022-12-01)

Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
by: Rengasamy Balakrishnan, et al.
Published: (2024-05-01)

Editorial: “Small molecules targeting transmembrane receptors and ion channels in drug discovery”
by: Rosa Maria Vitale, et al.
Published: (2023-05-01)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
by: Wei-cheng Lu, et al.
Published: (2020-08-01)

Using metabolomics to discover the immunomodulator activity of food plants
by: Novi Safriani, et al.
Published: (2022-05-01)